Unicorn Capital Partners — 2024 Investments

1 investments dated 2024 · listed companies and verified rows first · show all

Bluejaytxbluejaytx.comMay 2024acquired by Mirum Pharmaceuticals · Dec 2025 · $620M

Bluejay is a biotechnology company focused on therapeutic development.

BiotechSan Mateo, US

Keting Chu(Founder, Chief Executive Officer and Chairman of the Board)inDajun Yang(Director)Nancy Hong(Director)inAlon Lazarus(Director)William J. Rutter(Director)Ting Jia(Director)

Co-investorsFrazier Life Sciences RA Capital RiverVest Venture Partners Wellington Management Frazier Healthcare Partners HBM Healthcare Investments +2 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.